Literature DB >> 25107685

Prevalence and neuro-psychiatric comorbidities of pediatric epilepsy in Taiwan: a national population-based study.

Kuo-Liang Chiang1, Chen-Yang Cheng2.   

Abstract

OBJECTIVE: Children with epilepsy may have comorbidities that result in significant disability. Epidemiological information for pediatric patients with epilepsy in Taiwan is scant. This research estimates the prevalence and common neuro-psychiatric comorbidities of children with epilepsy in Taiwan.
METHODS: Patients aged less than 20 years old who had received a diagnosis of epilepsy and suffered from epileptic seizures in 2005 were identified in the NHIRD based on ICD-9-CM and prescription records for the use of at least one AED. We used cases of epileptic seizure to survey outpatient service data, and identify common neuro-psychiatric comorbidities. The crude prevalence rate and the age- and sex-specific prevalence were estimated. We also examined the effects of urbanization.
RESULTS: The estimated prevalence of epilepsy was 0.33% in the pediatric population, with 0.29% for girls and 0.36% for boys. The most common neuropsychiatric comorbidities were learning disability and developmental delay, cerebral palsy, and mental retardation. Epilepsy was more prevalent in boys than in girls, especially among infants, preschool children, and those living in rural areas. In addition, boys with epilepsy had a higher rate of neurological comorbidities. The prevalence of psychiatric comorbidities was lower than that reported in previous studies performed in other countries, especially among children with epilepsy living in rural areas.
CONCLUSION: This research provides the largest nationwide, population-based study of childhood epilepsy to estimate the prevalence and the associated neuropsychiatric comorbidities of pediatric epilepsy in Taiwan. Potential rural-urban disparity basing on prevalence and associated neuropsychiatric comorbidities cannot be ignored in Taiwan.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Comorbidity; National Health Insurance; Pediatric epilepsy; Prevalence; Taiwan; Urbanization

Mesh:

Year:  2014        PMID: 25107685     DOI: 10.1016/j.eplepsyres.2014.07.004

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  5 in total

1.  Association of epilepsy and asthma: a population-based retrospective cohort study.

Authors:  Kuo-Liang Chiang; Jen-Yu Lee; Fang-Chuan Kuo; Chin-Yin Huang
Journal:  PeerJ       Date:  2018-05-18       Impact factor: 2.984

2.  Parental perceptions of dental health and need for treatment in children with epilepsy: a multicenter cross-sectional study.

Authors:  Ahmed Hussein Subki; Abdel Moniem Mukhtar; Omar M Saggaf; Ragaa A Ali; Khalid A Khalifa; Dalia M Al-Lulu; Mohammed Saad Alsallum; Diyaa H Bokhary; Ayman M Baabdullah; Sulaiman M Kassar; Basil M Jan; Muhab M Hindi; Mohammed M Jan
Journal:  Pediatric Health Med Ther       Date:  2018-11-29

3.  Heterogeneous neurodevelopmental disorders in children with Kawasaki disease: what is new today?

Authors:  Chien-Heng Lin; Wei-De Lin; I-Ching Chou; Inn-Chi Lee; Syuan-Yu Hong
Journal:  BMC Pediatr       Date:  2019-11-04       Impact factor: 2.125

Review 4.  The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism.

Authors:  Hueng-Chuen Fan; Herng-Shen Lee; Kai-Ping Chang; Yi-Yen Lee; Hsin-Chuan Lai; Pi-Lien Hung; Hsiu-Fen Lee; Ching-Shiang Chi
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

5.  Comorbidities of epilepsy in low and middle-income countries: systematic review and meta-analysis.

Authors:  Aline Muhigwa; Pierre-Marie Preux; Daniel Gérard; Benoit Marin; Farid Boumediène; Charles Ntamwira; Chung-Huang Tsai
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.